Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice

Fundamental & Clinical Pharmacology
María Llorián-SalvadorLuis Menéndez

Abstract

Chemokine CCL2, also known as monocyte chemoattractant protein-1 (MCP-1), is a molecule that in addition to its well-established role in chemotaxis can also act as nociceptor sensitizer. The upregulation of this chemokine in inflamed tissues could suggest its involvement in inflammatory hypernociception. Thus, we have measured CCL2 levels in mice with acute or chronic inflammation due to the intraplantar (i.pl.) injection of carrageenan or complete Freund's adjuvant (CFA), respectively, and we have studied whether inflammatory hyperalgesia or allodynia could be attenuated by blocking CCR2 receptors or neutralizing CCL2 with an anti-CCL2 antibody. A remarkable increase in CCL2 concentration was detected by ELISA in paw homogenates coming from carrageenan- or CFA-inflamed mice, being its expression mainly localized in macrophages, as shown by immunohistochemical assays. The s.c. (0.3-3 mg/kg) or i.pl. (0.3-3 μg) administration of the CCR2 antagonist, RS 504393, dose dependently inhibited thermal hyperalgesia measured in acutely or chronically inflamed mice, whereas s.c. administration of this drug did not reduce inflammatory mechanical allodynia. Furthermore, the inhibition of inflammatory hyperalgesia after the administration of...Continue Reading

References

Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eva García-RamalloNuria Godessart
Jun 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Catherine AbbadieMichael J Forrest
Jul 28, 2005·Journal of Neuroscience Research·Xiaomei QinXian Wang
Oct 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carrie M BrodmerkelKris Vaddi
Jan 21, 2006·The British Journal of Ophthalmology·T OshimaT Ishibashi
Oct 21, 2006·International Immunopharmacology·Yifan WangYanping Le
Sep 2, 2008·The International Journal of Biochemistry & Cell Biology·Esther MelgarejoJosé Luis Urdiales
May 16, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Satish L DeshmaneBassel E Sawaya
May 16, 2009·Expert Opinion on Therapeutic Patents·James E Pease, Richard Horuk
Jul 22, 2010·Journal of Dental Research·N OguraT Kondoh
Dec 15, 2010·Molecular Pain·Alexandre SerranoChang Qing Cao
Feb 11, 2011·Fundamental & Clinical Pharmacology·Sara González-RodríguezLuis Menéndez
Apr 15, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Juliette Van SteenwinckelStéphane Mélik Parsadaniantz
Nov 16, 2011·Fundamental & Clinical Pharmacology·Hugo F MirandaMargarita M Puig
Dec 16, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mounir BelkouchPhilippe Sarret
Nov 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Rachel E MillerAnne-Marie Malfait
Dec 19, 2012·International Immunopharmacology·Leah A MitchellSteven W Dow
Apr 19, 2013·American Journal of Physiology. Renal Physiology·Lauren ArmsMargaret A Vizzard
May 21, 2013·The Journal of Pain : Official Journal of the American Pain Society·Diana PflückeHeike L Rittner
Jun 4, 2013·The Journal of Pain : Official Journal of the American Pain Society·Haijun ZhangPatrick M Dougherty
Aug 21, 2013·Journal of Pharmacology & Pharmacotherapeutics·Masayuki OkamotoNobuhide Watanabe
May 23, 2014·Pflügers Archiv : European journal of physiology·Stéphane LolignierJohn N Wood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here